Advancing Clinical Research Across Diverse Communities
Quality Medical Research (QMR) connects sponsors and CROs with diverse patient populations across Nashville, Middle Tennessee, and surrounding regions. Through established physician relationships, community connections, and experienced research professionals, we support inclusive recruitment across a broad range of therapeutic areas.
Our multilingual team, including on-site Spanish-speaking research professionals, helps foster meaningful patient engagement and representative clinical trial participation.
Our Recruitment Strengths
- Diverse Patient Access: Urban, suburban, and rural communities spanning a broad range of racial, ethnic, and socioeconomic backgrounds.
- Established Clinical Networks: Physician relationships and community connections supporting patient identification and recruitment.
- Inclusive Patient Engagement: Multilingual, culturally responsive communication that supports participation and retention.
Demographics of Our Regional Population
The Nashville–Davidson–
Source: U.S. Census Bureau, 2024 American Community Survey.
Clinical Trial Capabilities
Phase I–IV clinical trial capabilities
Central IRB coordination and experienced regulatory support
Expedited contracting, budgeting, and study start-up
Dedicated patient recruitment and enrollment coordination
Scalable staffing for high-volume and time-sensitive studies
Rapid-start, add-on, replacement, and rescue-site opportunities
Broad Therapeutic Capabilities
QMR supports clinical research across a growing range of therapeutic areas, leveraging our physician relationships and diverse regional patient population to identify qualified participants and pursue new study opportunities.
Gastroenterology and Hepatology
- Irritable bowel syndrome (IBS)
- Inflammatory bowel disease (IBD)
- Gastroesophageal reflux disease (GERD)
- Chronic constipation and other digestive disorders
- Metabolic dysfunction-associated steatotic liver disease (MASLD)
- Metabolic dysfunction-associated steatohepatitis (MASH)
- Liver fibrosis and other chronic liver conditions
Metabolic and Cardiometabolic Medicine
- Obesity and weight management
- Type 2 diabetes mellitus
- Prediabetes and insulin resistance
- Hypertension
- Dyslipidemia
- Cardiometabolic risk reduction
Primary Care and General Medicine
- Common chronic medical conditions
- Preventive medicine and disease prevention
- Respiratory and infectious diseases
- Primary care-based therapeutic studies
- General internal medicine research
Vaccines and Infectious Disease Prevention
- Adult vaccine clinical trials, including Phase II–IV studies
- Influenza, COVID-19, RSV, and combination respiratory vaccines
- Pneumococcal, herpes zoster, and other adult immunizations
- Norovirus, C. difficile, CMV, EBV, and Lyme disease vaccine development
- Vaccine safety, immunogenicity, efficacy, and booster studies
- Healthy-volunteer and community-based vaccine research
Nephrology and Renal Medicine
- Chronic kidney disease (CKD)
- Diabetic kidney disease
- Hypertension-associated kidney disease
- Albuminuria and renal function preservation
- Renal and cardiovascular risk reduction
- Investigational therapies targeting kidney health and disease progression
QMR SITE POSITIONING
QMR is an experienced independent clinical research site in Middle Tennessee with access to a broad adult/community patient population, experienced investigators, dedicated research and enrollment personnel, and the infrastructure to rapidly activate and execute Phase II-IV clinical trials.
Advanced Clinical Research & Participant Monitoring
Supporting complex Phase I-IV clinical trials requiring enhanced investigational product management, intensive safety assessments, and extended participant observation. Our multilingual team, including on-site Spanish-speaking research professionals, helps foster meaningful patient engagement and representative clinical trial participation.
Investigational Product Management
Secure, temperature-controlled storage and
monitoring
Intensive Protocols & Extended Visits
Serial assessments, timed specimen collection, and overnight observation
Clinical Oversight & Safety
24-hour clinical coverage, safety monitoring, and emergency escalation protocols
Experienced, Dedicated Research Team
Led by experienced investigators and clinical research leadership, QMR provides dedicated study coordination, patient recruitment, regulatory oversight, and streamlined study start-up across multiple therapeutic areas.
Leadership & Investigators
- VP of Clinical Research Operations
- 2 seasoned Principal Investigators with 60+ combined clinical trials as well as 3 Sub- Investigators
Study Execution
- 3 full-time Clinical Research Coordinators
- 1 full-time Clinical Research Assistant
Enrollment & Regulatory
- 1 full-time Clinical Research Enrollment Coordinator
- Dedicated Regulatory Specialist
Vaccine & Infectious Disease Research Capabilities
Priority Indications
- Seasonal and pandemic influenza; COVID-19; RSV; influenza/COVID combination; pneumococcal; norovirus; C. difficile; CMV; herpes zoster; UTI; EBV; Lyme disease; and other adult infectious-disease vaccines.
Study Types
- Phase II-IIIB pivotal programs; Phase IV/post- marketing studies; healthy-volunteer studies; immunogenicity and safety studies; booster/revaccination studies; and large multi-site enrollment programs.
Specialty Advantage
- GI expertise can provide additional value for norovirus, C. difficile, infectious GI disease, chronic liver disease populations, and related protocols while QMR remains positioned for broad adult/community recruitment.
Advanced Clinical Research & Participant Monitoring Capabilities
- QMR also maintains infrastructure to support studies requiring enhanced investigational product management and extended participant observation. Our capabilities include secure on-site investigational product storage with appropriate temperature controlled storage and monitoring, after-hours and overnight coverage, and on-site bed space for participants requiring prolonged or overnight observation.
- PROTOCOLS & VISITS
- Our clinical and research teams can support protocols requiring extended post-dose monitoring, serial assessments, time-sensitive specimen collection, and overnight study visits.
- VACCINE INTENSIVE & ESCALATION
- For vaccine studies, QMR can accommodate protocols requiring extended post-vaccination observation and overnight monitoring, including studies with intensive post-dose safety assessments and serial clinical evaluations. We can also accommodate protocols requiring 24-hour clinical coverage and maintain established processes for clinical escalation and emergency response when indicated.
Feel free to contact us to learn more.
Contact Us
(615) 835-4720
studies@thegidocs.com
Address
330 Wallace Road Suite 103 Nashville, TN 37211
Partnership Opportunities
QMR is actively seeking direct sponsor and CRO partnerships for current and upcoming clinical trials. We welcome feasibility requests and are particularly interested in rapid-start, add-on, replacement, and rescue-site opportunities where experienced investigators, dedicated recruitment resources, and efficient start-up can accelerate execution.
- SITE CONTACT